The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
Ontology highlight
ABSTRACT: The Liver X Receptors (LXRs) are oxysterol-activated transcription factors that upregulate a suite of genes that together promote coordinated mobilization of excess cholesterol from cells and from the body. The LXRs, like other nuclear receptors, are anti-inflammatory, inhibiting signal-dependent induction of pro-inflammatory genes by nuclear factor-κB, activating protein-1, and other transcription factors. Synthetic LXR agonists have been shown to ameliorate atherosclerosis and a wide range of inflammatory disorders in preclinical animal models. Although this has suggested potential for application to human disease, systemic LXR activation is complicated by hepatic steatosis and hypertriglyceridemia, consequences of lipogenic gene induction in the liver by LXRα. The past several years hav
SUBMITTER: Fessler MB
PROVIDER: S-EPMC5743771 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA